XHKG
0255
Market cap110mUSD
Oct 08, Last price
1.37HKD
1D
0.74%
1Q
-6.16%
Jan 2017
-47.31%
Name
Lung Kee Bermuda Holdings Ltd
Chart & performance
P/E
—
P/S
0.66
EPS
—
Div yield, %
18.98%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
-8.56%
Revenues
1.32b
-15.02%
Net income
-23m
L+65.41%
CFO
213m
-5.77%
Dividend
Sep 04, 20260.08 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Lung Kee Group Holdings Limited, an investment holding company, manufactures and markets mould bases and related products in the People's Republic of China and internationally. The company also engages in the property investment and corporate management activities. The company was formerly known as Lung Kee (Bermuda) Holdings Limited and changed its name to Lung Kee Group Holdings Limited in June 2024. The company was founded in 1975 and is headquartered in Sha Tin, Hong Kong. Lung Kee Group Holdings Limited is a subsidiary of Pan Island Investments Limited.
Key people
Yuk Lung Siu
Managing Director, Executive Director · since 1992
Tit Lung Siu
Executive Chairman of the Board · since 1992
Yu Hang Siu
Executive Director · since 2017
Yuk Tung Siu
Executive Director · since 2017
Chung Ho Ting
Executive Director · since 2008
Lung Shing Wai
Company Secretary, Executive Director · since 1992
Lamei He
Independent Non-Executive Director · since 2022
Tat Yee Lee
Independent Non-Executive Director · since 1992
Independent Non-Executive Director · since 2018
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||